COCAINE USE DISORDER
Clinical trials for COCAINE USE DISORDER explained in plain language.
Never miss a new study
Get alerted when new COCAINE USE DISORDER trials appear
Sign up with your email to follow new studies for COCAINE USE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cash for clean tests: App-Based rewards tested in older drug users
Disease control OngoingThis study tests whether an app that gives financial rewards for drug-negative saliva tests works for older adults with opioid, cocaine, or methamphetamine use disorder. Researchers will compare results between older and younger participants to see if age affects how well the app…
Matched conditions: COCAINE USE DISORDER
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Can a phone app with cash rewards help people beat opioid and cocaine addiction?
Disease control OngoingThis study tests whether a smartphone app can help people who are already on methadone treatment cut down on opioid and cocaine use. The app asks participants to take random drug tests at home and rewards them with money for negative results. Researchers want to see if app users …
Matched conditions: COCAINE USE DISORDER
Phase: PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New digital app aims to curb cocaine and meth use
Disease control ENROLLING_BY_INVITATIONThis pilot study tests a web-based program called LDART for adults with stimulant use disorder (cocaine or methamphetamine). The program includes daily goal setting, motivational messages from people in recovery, and links to support groups. Researchers want to see if it's feasib…
Matched conditions: COCAINE USE DISORDER
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Diabetes drug exenatide studied as potential cocaine addiction treatment
Disease control TerminatedThis study aimed to test whether exenatide (Bydureon), a drug approved for type 2 diabetes, could safely reduce the urge to use cocaine. Researchers planned to give the drug or a placebo to people with cocaine use disorder and measure how many cocaine doses they chose to take. Ho…
Matched conditions: COCAINE USE DISORDER
Phase: PHASE1 • Sponsor: Christopher D. Verrico • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Magic mushroom compound tested for cocaine addiction safety
Symptom relief TerminatedThis study looks at whether a single 25 mg dose of psilocybin (the active ingredient in magic mushrooms) can be safely given to people with cocaine use disorder who want to quit. Ten adults from Los Angeles will take the drug in a comfortable room with two clinicians present, and…
Matched conditions: COCAINE USE DISORDER
Phase: EARLY_PHASE1 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Brain training study for cocaine use disorder falls through
Knowledge-focused TerminatedThis study aimed to see if a brain training method called ZQLN could improve brain activity and thinking skills in people with cocaine use disorder. It planned to enroll adults aged 21 to 51 who had completed detox. However, the study was withdrawn before any participants were en…
Matched conditions: COCAINE USE DISORDER
Phase: NA • Sponsor: University of Puerto Rico • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Ritalin may help erase cocaine memories, early study suggests
Knowledge-focused OngoingThis study tests whether methylphenidate (Ritalin) can help weaken memories that link drug cues to cocaine use. Fifty-one adults with cocaine use disorder will receive either methylphenidate or a placebo before recalling drug-related memories, while brain activity and skin respon…
Matched conditions: COCAINE USE DISORDER
Phase: EARLY_PHASE1 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:44 UTC